Development of nasal vaccines and the associated challenges
X Nian, J Zhang, S Huang, K Duan, X Li, X Yang - Pharmaceutics, 2022 - mdpi.com
Viruses, bacteria, fungi, and several other pathogenic microorganisms usually infect the host
via the surface cells of respiratory mucosa. Nasal vaccination could provide a strong …
via the surface cells of respiratory mucosa. Nasal vaccination could provide a strong …
Next Generation RNA/Protein‐Carrying Vector With Pleiotropic Activity
T Nosaka, J Ohtsuka, T Ohtsuka… - Reviews in Medical …, 2024 - Wiley Online Library
Human parainfluenza virus type 2 (hPIV2), one of the causative agents of infantile common
cold, is a non‐segmented negative‐sense RNA virus with a robust gene expression system …
cold, is a non‐segmented negative‐sense RNA virus with a robust gene expression system …
Characterization of systemic and mucosal humoral immune responses to an adjuvanted intranasal SARS-CoV-2 protein subunit vaccine candidate in mice
Continuous viral evolution of SARS-CoV-2 has resulted in variants capable of immune
evasion, vaccine breakthrough infections and increased transmissibility. New vaccines that …
evasion, vaccine breakthrough infections and increased transmissibility. New vaccines that …
[PDF][PDF] Development of Nasal Vaccines and the Associated Challenges. Pharmaceutics 2022, 14, 1983
X Nian, J Zhang, S Huang, K Duan, X Li, X Yang - 2022 - pdfs.semanticscholar.org
Viruses, bacteria, fungi, and several other pathogenic microorganisms usually infect the host
via the surface cells of respiratory mucosa. Nasal vaccination could provide a strong …
via the surface cells of respiratory mucosa. Nasal vaccination could provide a strong …
Characterization and Vaccine Strategy Development for Circulating and Emerging Respiratory Viruses
M Maltseva - 2025 - ruor.uottawa.ca
The ongoing evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
and the emergence of highly transmissible variants of this virus have significantly impacted …
and the emergence of highly transmissible variants of this virus have significantly impacted …
Potencial oncolítico del virus de la enfermedad de Newcastle en líneas celulares tumorales
GI Guerrero Fonseca - 2024 - repositorio.unica.edu.pe
La viroterapia se ha convertido en una opción terapéutica prometedora en el tratamiento del
cáncer. El virus de la enfermedad de Newcastle (NDV) causa una infección altamente …
cáncer. El virus de la enfermedad de Newcastle (NDV) causa una infección altamente …
The development and evaluation of medical countermeasures against severe acute respiratory syndrome coronavirus type 2
J Sookhoo - 2024 - mspace.lib.umanitoba.ca
The SARS-CoV-2 pandemic has demonstrated the need for faster and more efficient ways to
produce diagnostics, therapeutics and vaccines against unknown infectious diseases. This …
produce diagnostics, therapeutics and vaccines against unknown infectious diseases. This …